Airway diseases
Interstitial lung diseases
Clinical trials session
ALERT: Asthma in adult, in children and ILDs
Aims : Including the ALERT sessions (Abstracts Leading to Evolution in
Respiratory Medicine Trials), these formats showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, session chairs and viewers will take part lively discussions on the presented trials.
Methods :
General respiratory patient care, Pulmonary rehabilitation
09:30
Introduction
1
RCT2898
09:34
Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO)
S. Turner(Aberdeen (Aberdeenshire), United Kingdom)
COI
2
09:41
Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma
S. Siddiqui(London, United Kingdom)
COI
3
09:48
Breathing exercises for specialist care asthma patients: a multicentre randomised trial
K. Andreasson(Næstved, Denmark)
COI
4
09:55
Wrap-up by discussant and discussion
C. Porsbjerg(Copenhagen, Denmark)
COI
5
RCT2902
10:15
RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial
J. Naccache(Paris, France)
COI
6
10:22
Results of a phase 2 study of GLPG1205 for idiopathic pulmonary fibrosis (PINTA)
V. Cottin(Lyon, France)
COI
7
10:29
Late Breaking Abstract - Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis (FITNESS study)
T. Ogura(Yokohama, Japan)
COI
8
10:36
Wrap-up by discussant and discussion
V. Cottin(Lyon, France)
COI
9
RCT2906
10:56
Closing remarks
10
RCT2907
. . .
